<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02400879</url>
  </required_header>
  <id_info>
    <org_study_id>KUH-1160080</org_study_id>
    <nct_id>NCT02400879</nct_id>
  </id_info>
  <brief_title>Remifentanil Anesthesia and Postoperative BIS in Cardiac Surgery</brief_title>
  <official_title>Comparisons of Postoperative BIS Profile and Extubation Time After Valvular Heart Surgery: Remifentanil-based Propofol-supplemented Versus Sevoflurane-sufentanil Balanced Anesthesia Regimen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Although remifentanil based anesthesia has been preferred for fast-track cardiac&#xD;
      anesthesia, its recovery profile in cognitive function has not been investigated. Authors&#xD;
      determined postoperative Bispectral index (BIS) score as well as extubation time after&#xD;
      remifentanil-based propofol-supplemented anesthesia and compared them with those after&#xD;
      conventional balanced sevoflurane-sufentanil anesthesia.&#xD;
&#xD;
      Methods: Patients undergoing cardiac surgery using moderate hypothermic cardiopulmonary&#xD;
      bypass (CPB) will be randomly allocated to get remifentanil-based propofol-supplemented&#xD;
      (Group R) or conventional sevoflurane-sufentanil regimen (Group C) in the study period. For&#xD;
      anesthetic induction and maintenance, fixed target controlled infusion (TCI) of remifentanil&#xD;
      (plasma concentration 20 ng/ml) and TCI-propofol for maintaining BIS score 40-60 (effect&#xD;
      concentration 0.8-1.5 μg/ml) in Group R, and TCI-sufentanil (Cp 0.4- 0.8 ng/ml) and&#xD;
      sevoflurane inhalation for maintaining 80-120 % of baseline BP and BIS &lt; 60 (&lt; 1.5 MAC) in&#xD;
      Group C, respectively.&#xD;
&#xD;
      Authors will analyze postoperative recovery of cognitive function by using BIS after the use&#xD;
      of remifentanil-based propofol-supplemented anesthesia for cardiac surgery and to compare&#xD;
      them to those after the use of conventional balanced sevoflurane-sufentanil anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Backgrounds Since opioid-based anesthesia does not produce dose-dependent myocardial&#xD;
      depression, it has been applied for patients undergoing cardiac surgery with myocardial&#xD;
      dysfunction.&#xD;
&#xD;
      However, prolonged use of conventional opioids in a large dosage delays patient's&#xD;
      postoperative recovery due to their longer half-life and accumulation of their metabolites.&#xD;
&#xD;
      Fast-track cardiac anesthesia which reducing the duration of postoperative mechanical&#xD;
      ventilation and length of stay (LOS) in the intensive care unit (ICU) is beneficial not only&#xD;
      in reducing ventilator-related complications and medical expense but in improving patient's&#xD;
      outcome.&#xD;
&#xD;
      For this purpose, in addition to supplementation of neuraxial blockade, use of short-acing&#xD;
      opioid, such as remifentanil, has been advocated for cardiac anesthesia. Remifentanil is an&#xD;
      ultra-short acting opioid and provides not only stable hemodynamics, as other opioid does,&#xD;
      and but fast recovery, even after prolonged use in a large dosage. In further, recent&#xD;
      investigations showed that remifentanil provides preconditioning effect in myocardial&#xD;
      ischemia injury during cardiac surgery, as like in the use of volatile anesthetics including&#xD;
      sevoflurane.&#xD;
&#xD;
      Remifentanil vs volatile anesthetics In spite of the importance of recovery of cognitive&#xD;
      function on whole postoperative clinical features, most investigations have evaluated only&#xD;
      the postoperative respiratory profile in determining the speed of postoperative recovery&#xD;
      specific to the choice of anesthesia regimen.&#xD;
&#xD;
      Bispectral index (BIS) monitoring has been used to monitor sedation depth, to avoid&#xD;
      introperative awareness and to adjust the dosage of intraoperative hypnotics. Several&#xD;
      investigations tried to find BIS's efficacy in managing sedation of critically ill patients.&#xD;
      In spite of some controversies, BIS monitoring seem to be beneficial: it does not require&#xD;
      additional stimuli to determine sedation level which is essential in other subjective&#xD;
      modalities, such as Ramsay score, and usually compromises the already instituted patient's&#xD;
      sedation level.&#xD;
&#xD;
      Authors will analyze postoperative recovery of cognitive function by using BIS as well as&#xD;
      respiratory profiles after the use of remifentanil-based propofol-supplemented anesthesia for&#xD;
      cardiac surgery and to compare them to those after the use of conventional balanced&#xD;
      sevoflurane-sufentanil anesthesia.&#xD;
&#xD;
      Methods Population and Study Protocol After obtaining Institutional Review Board approval and&#xD;
      informed consents from the patients, they are prospectively studied among patients undergoing&#xD;
      cardiac valve repair or replacement surgery under moderate hypothermic cardiopulmonary bypass&#xD;
      (CPB).&#xD;
&#xD;
      During the study period (6 months), at least, forty patients are randomly allocated into&#xD;
      following one of two groups using sealed envelopes: remifentanil-based propofol-supplemented&#xD;
      anesthesia regimen is employed in Group R and conventional balanced sevoflurane-sufentanil&#xD;
      anesthesia regimen in Group C, respectively.&#xD;
&#xD;
      Preoperative and intraoperative exclusion criteria Preoperative exclusion criteria 1) urgent&#xD;
      or emergent surgery, 2) left ventricle (LV) ejection fraction &lt; 50%, 3) application of&#xD;
      intraaortic balloon pump (IABP), 4) myocardial infarction, 5) neurologic deficit, 6) hepatic&#xD;
      or renal impairment, 7) pacing, 8) inotropic medication, 9) neurologic deficit.&#xD;
&#xD;
      Intraoperative exclusion criteria&#xD;
&#xD;
      1) CPB application &gt; 250 min, 2) transfused of packed red blood cell (pRBC) &gt; 5 units, 3)&#xD;
      post-CPB use of double inotropic support &gt; 30 min , 4) post-CPB pacing, 5) IABP 6) IABP 7)&#xD;
      postoperative hemodialysis, 8) excessive bleeding &gt; 750 ml during postoperative 6 hour, 9)&#xD;
      reoperation due to excessive bleeding.&#xD;
&#xD;
      All data were collected by trained observers who did not participate in patient care and who&#xD;
      were blinded to the current study.&#xD;
&#xD;
      Anesthesia regimen After establishing routine invasive arterial blood pressure and&#xD;
      noninvasive patient monitoring such as pulse oximetry (SpO2), electrocardiography, bispectral&#xD;
      index (BIS) and cerebral oximetry, anesthesia is induced by two staff anesthesiologist (AA&#xD;
      and BB) using a target controlled infusion (TCI) of propofol (effect site concentration, Ce,&#xD;
      of 2.0 µg/ml) and remifentanil (plasma concentration, Cp, of 20 ng/ml with the time to reach&#xD;
      target concentration of 7 min) in Group R (by AA), and anesthesia is induced by bolus&#xD;
      injection of thiopental sodium 3-4 mg/kg and maintained using TCI- sufentanil (Cp of 0.4&#xD;
      ng/ml) in Group C (by BB). Muscle relaxation and tracheal intubation is facilitated by bolus&#xD;
      rocuronium under the guidance of peripheral neuromuscular transmission.&#xD;
&#xD;
      For anesthesia maintenance, TCI-remifentanil (fixed Cp of 20 ng/ml) and TCI-propofol&#xD;
      (variable Ce &lt; 2.0 µg/ml) for maintaining BIS 40-60 in Group R [14], and TCI-sufentnail (Cp&#xD;
      of 0.4-0.8 ng/ml) and sevoflurane (&lt; 1.5 MAC) for maintaining 80-120 % of preoperative value&#xD;
      and BIS &lt; 60 in Group C, respectively. Rocuronium is continuously infused (3 µg/kg/min) in&#xD;
      both groups.&#xD;
&#xD;
      Controlled ventilation of O2/air mixture (FiO2 0.5-0.6) is performed with following setting&#xD;
      of anesthesia ventilator (ADU™, Datex-Ohmeda, Finland): tidal volume of 7 ml/ideal body&#xD;
      weight (calculated by obsolete formulas), respiratory rate maintain normocarbia (end-tidal&#xD;
      CO2 tension 35-40 mmHg) and inspiratory:expiratory ratio of 1:2.&#xD;
&#xD;
      Pulmonary artery catheter (Swan-GanzCCOmboCCO/SvO2, Edwards Lifesciences, Irvine, USA) and a&#xD;
      probe of transesophageal echocardiography were placed after anesthesia induction.&#xD;
&#xD;
      If high BIS score (&gt; 60) persisted against the increase of sevoflurane to 1.5 MAC in Group C&#xD;
      or Ce of propofol to 2.0 μg/ml in Group R, bolus midazolam 2 mg is administered.&#xD;
&#xD;
      Surgery and CPB regimen All surgery is performed by one surgeon and 4 surgical assistants.&#xD;
      After performing sternotomy and administration of heparin 300 units/kg, arterial and venous&#xD;
      cannulations for CPB are performed at activated clotting time (ACT) &gt; 450 sec and CPB was&#xD;
      conducted using reservoir, membrane oxygenator, roller pump and heat exchanger. Priming&#xD;
      volume for CPB was composed of normal saline, 20% mannitol, NaHCO3, 20% albumin, heparin,&#xD;
      antibiotics and calcium gluconate. The flow of CPB is initiated at 60 ml/kg/min and adjusted&#xD;
      by the current hemodilution and temperature.&#xD;
&#xD;
      Antegrade or retrograde administration of cold cardioplegic solution (20 ml/kg) consisting of&#xD;
      drained patient's blood, NaCl 6.43 g/L, KCl 1.193 g/L, CaCl2 0.176 g/L and MgCl2 3.253 g/L&#xD;
      (pH 7.4 at 4 - 8 °C) is applied as appropriate for cardiac protection after application of&#xD;
      aortic cross clamp (ACC).&#xD;
&#xD;
      Transfer to intensive care unit (ICU) and postoperative pain control After surgery, the&#xD;
      patients are transferred to the ICU in intubated status and received controlled or assisted&#xD;
      ventilation till the time of extubation. In Group R, remifentanil 0.25-0.3 μg /kg/min is&#xD;
      continued till the time of extubation.&#xD;
&#xD;
      For postoperative pain control, the intravenous patient control analgesia consisting of&#xD;
      alfentanil, ketorolac, and ondansetron is started at the time of sterna closure in Group C or&#xD;
      at 20 min before extubation in Group R, respectively.&#xD;
&#xD;
      Protocols of ventilator weaning and extubation The mode of ventilator is converted from&#xD;
      volume controled ventilation (CMV) to synchronized intermittent mandatory ventilation (SIMV)&#xD;
      when the following criteria were achieved: stable hemodynamics, self respiration, and the&#xD;
      respiratory rate 10-25 breaths/min [15].&#xD;
&#xD;
      The patients are extubated when the following criteria are achieved: awake state, stable&#xD;
      hemodynamics, normal airway reflex, respiratory rate 10-25 breath/min, SpO2 &gt; 95% at FiO2 &lt;&#xD;
      0.6, pH ≥ 7.3 and PaCO2 &lt; 55 mmHg.&#xD;
&#xD;
      Measurements Operation time, CPB time, ACC time, intraoperative fluid administration&#xD;
      quantity, transfusion requirements, intraoperative urine output (UO), preoperative and&#xD;
      postoperative hematocrit (Hct) and preoperative and postoperative PaO2/FiO2 ratio are&#xD;
      recorded.&#xD;
&#xD;
      The duration from the end of surgery to the time of achieving BIS score &gt; 80 (persisting &gt; 3&#xD;
      min) (T-BIS80) [16], the duration from end of surgery to the time of initiating SIMV (T-SIMV)&#xD;
      and the duration from the end of surgery to the time of extubation (T-extubation) are&#xD;
      measured.&#xD;
&#xD;
      Statistical analysis The primary outcome variables are T-BIS80, T-SIMV, and T-extubation.&#xD;
      Statistics are performed using the program Sigmastat ver.3.1(Systat Software Inc, San Jose,&#xD;
      USA). Continuous variables were analyzed by a t-test, while categorical variables are by a&#xD;
      chi-square test between two groups. The data collected are expressed as mean and standard&#xD;
      deviation, numbers of patients or absolute numbers. A P value &lt; 0.05 is considered&#xD;
      significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to achieving BIS&gt;80</measure>
    <time_frame>5 min</time_frame>
    <description>The duration from the end of surgery to the time of achieving BIS score &gt; 80 (BIS&gt;80 persisting &gt; 3 min)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to achieve SIMV ventilation mode</measure>
    <time_frame>5 min</time_frame>
    <description>the duration from end of surgery to the time of initiating SIMV (T-SIMV)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to achieve extubation</measure>
    <time_frame>5 min</time_frame>
    <description>the duration from the end of surgery to the time of extubation (T-extubation)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Remifentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For anesthesia maintenance, TCI-remifentanil (fixed Cp of 20 ng/ml) and TCI-propofol (variable Ce &lt; 2.0 µg/ml) for maintaining BIS 40-60</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane and sufentanil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TCI-sufentnail (Cp of 0.4-0.8 ng/ml) and sevoflurane (&lt; 1.5 MAC) for maintaining 80-120 % of preoperative value and BIS &lt; 60</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>administering remifentanil infusion 0.7-0.8 mcg/kg/min for anesthesia maintenance</description>
    <arm_group_label>Remifentanil</arm_group_label>
    <other_name>ultiva, GSK</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane and sufentanil</intervention_name>
    <description>administering sevoflurane and sufentanil for anesthesia maintenance</description>
    <arm_group_label>sevoflurane and sufentanil</arm_group_label>
    <other_name>sevorane and sufental</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients undergoing cardiac valve repair or replacement surgery under moderate&#xD;
             hypothermic cardiopulmonary bypass (CPB).&#xD;
&#xD;
          2. All patients should provide written informed consents&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Preoperative exclusion criteria&#xD;
&#xD;
          1. urgent or emergent surgery,&#xD;
&#xD;
          2. left ventricle (LV) ejection fraction &lt; 50%,&#xD;
&#xD;
          3. application of intraaortic balloon pump (IABP),&#xD;
&#xD;
          4. myocardial infarction,&#xD;
&#xD;
          5. neurologic deficit,&#xD;
&#xD;
          6. hepatic or renal impairment,&#xD;
&#xD;
          7. pacing,&#xD;
&#xD;
          8. inotropic medication,&#xD;
&#xD;
          9. neurologic deficit.&#xD;
&#xD;
        Intraoperative exclusion criteria&#xD;
&#xD;
          1. CPB application &gt; 250 min,&#xD;
&#xD;
          2. transfused of packed red blood cell (pRBC) &gt; 5 units,&#xD;
&#xD;
          3. post-CPB use of double inotropic support &gt; 30 min ,&#xD;
&#xD;
          4. post-CPB pacing,&#xD;
&#xD;
          5. IABP&#xD;
&#xD;
          6. IABP&#xD;
&#xD;
          7. postoperative hemodialysis,&#xD;
&#xD;
          8. excessive bleeding &gt; 750 ml during postoperative 6 hour,&#xD;
&#xD;
          9. reoperation due to excessive bleeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tae-Yop Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konkuk Univeristy Medical Center</affiliation>
  </overall_official>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>March 15, 2015</study_first_submitted>
  <study_first_submitted_qc>March 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2015</study_first_posted>
  <last_update_submitted>August 17, 2020</last_update_submitted>
  <last_update_submitted_qc>August 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>bispectral index</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>recovery</keyword>
  <keyword>remifentanil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

